DK1165595T3 - Leverspecifikke galdesyre-derivater af glucocorticoid-receptorantangonisten RU486 - Google Patents

Leverspecifikke galdesyre-derivater af glucocorticoid-receptorantangonisten RU486

Info

Publication number
DK1165595T3
DK1165595T3 DK00922530T DK00922530T DK1165595T3 DK 1165595 T3 DK1165595 T3 DK 1165595T3 DK 00922530 T DK00922530 T DK 00922530T DK 00922530 T DK00922530 T DK 00922530T DK 1165595 T3 DK1165595 T3 DK 1165595T3
Authority
DK
Denmark
Prior art keywords
liver
glucocorticoid receptor
acid derivatives
receptor antagonist
bile acid
Prior art date
Application number
DK00922530T
Other languages
Danish (da)
English (en)
Inventor
Theresa Apelqvist
Jinchang Wu
Konrad F Koehler
Original Assignee
Karobio Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karobio Ab filed Critical Karobio Ab
Application granted granted Critical
Publication of DK1165595T3 publication Critical patent/DK1165595T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00922530T 1999-03-27 2000-03-18 Leverspecifikke galdesyre-derivater af glucocorticoid-receptorantangonisten RU486 DK1165595T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9907048.4A GB9907048D0 (en) 1999-03-27 1999-03-27 Novel glucocorticoid receptor ligands for the treatment of meta bolic disorders
PCT/EP2000/002429 WO2000058337A1 (fr) 1999-03-27 2000-03-18 Derives d'acides biliaires specifiques au foie provenant de l'antagoniste de glucocorticoides ru486

Publications (1)

Publication Number Publication Date
DK1165595T3 true DK1165595T3 (da) 2003-09-15

Family

ID=10850457

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00922530T DK1165595T3 (da) 1999-03-27 2000-03-18 Leverspecifikke galdesyre-derivater af glucocorticoid-receptorantangonisten RU486

Country Status (13)

Country Link
US (1) US6468975B1 (fr)
EP (1) EP1165595B1 (fr)
JP (1) JP2002540215A (fr)
KR (1) KR20020002486A (fr)
AT (1) ATE240346T1 (fr)
AU (1) AU758654B2 (fr)
CA (1) CA2367792A1 (fr)
DE (1) DE60002692T2 (fr)
DK (1) DK1165595T3 (fr)
ES (1) ES2197091T3 (fr)
GB (1) GB9907048D0 (fr)
PT (1) PT1165595E (fr)
WO (1) WO2000058337A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1267898A4 (fr) * 2000-04-07 2006-02-01 Univ Maryland Promedicaments contenant un acide biliaire et presentant une meilleure biodisponibilite
DK1551860T3 (da) * 2002-06-19 2007-04-02 Karobio Ab Glukokortikoid-receptorligander til behandling af stofskifteforstyrrelser
US7141559B2 (en) 2002-06-19 2006-11-28 Karo Bio Ab Glucocorticoid receptor ligands for the treatment of metabolic disorders
US9216221B2 (en) 2008-11-07 2015-12-22 University Of Sheffield Medicament and method of diagnosis for treating subclinical Cushing's syndrome
BR112014009790A2 (pt) 2011-10-25 2018-05-15 Isis Pharmaceuticals Inc composto para modulação antisense da expressão de gccr, seu uso e composição

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441129A (en) * 1942-05-23 1948-05-11 Berczeller Arpad Bile acid derivatives of aryl sulfonamides
US4418059A (en) * 1981-07-20 1983-11-29 Montefiore Medical Center Nucleoside ester compositions
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
WO1998027986A1 (fr) 1996-12-24 1998-07-02 Zymogenetics, Inc. Agents therapeutiques et procedes de traitement du diabete de type ii et symptomes du diabete de type ii
KR20010052431A (ko) * 1998-06-08 2001-06-25 오테스코그 페르 당뇨병 치료제

Also Published As

Publication number Publication date
ATE240346T1 (de) 2003-05-15
WO2000058337A1 (fr) 2000-10-05
KR20020002486A (ko) 2002-01-09
PT1165595E (pt) 2003-08-29
GB9907048D0 (en) 1999-05-19
AU4289300A (en) 2000-10-16
EP1165595B1 (fr) 2003-05-14
JP2002540215A (ja) 2002-11-26
AU758654B2 (en) 2003-03-27
ES2197091T3 (es) 2004-01-01
CA2367792A1 (fr) 2000-10-05
DE60002692T2 (de) 2004-03-25
DE60002692D1 (de) 2003-06-18
EP1165595A1 (fr) 2002-01-02
US6468975B1 (en) 2002-10-22

Similar Documents

Publication Publication Date Title
ATE496620T1 (de) 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
NO20021358D0 (no) Alkylendiamin-substituerte heterocykler
TR200100238T2 (tr) Yeni sübstitüe edilmiş pirazol türevleri
DE60322713D1 (de) Substituierte dihydrochinoline als glucocorticoid-mmimetika,verfahren zu deren herstellung, pharmazeutische zubereitungen und deren verwendung
DE69912581D1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
DE69926806D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
ATE496893T1 (de) Isochinolinonderivate und deren verwendung als medikamente
EA200400466A1 (ru) Производные пиперазина с антагонистической активностью к рецептору ccr1
WO2005030120A3 (fr) Agents anti-angiogenese
ATE543803T1 (de) 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren
WO2003063787A3 (fr) Analogues non steroidiens de 2-methoxyestradiol
DK1401432T3 (da) Natriumkanalmodulerende imidazolderivater
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
ATE236153T1 (de) 4-trifluormethyl-3-oxazolylpyridine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
ATE367380T1 (de) Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate
ATE269340T1 (de) Thiazolopyrimidine und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität
DK1363876T3 (da) Glucocorticoidreceptormodulatorer
WO2002042319A3 (fr) Antiangiogènes
BRPI0507987A (pt) métodos e compostos moduladores receptor de glicocorticóide
NZ516397A (en) Aminothiazole derivatives and their use as CRF receptor ligands
DK1165595T3 (da) Leverspecifikke galdesyre-derivater af glucocorticoid-receptorantangonisten RU486
DE60311887D1 (de) Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
DK1196428T3 (da) 11-beta-aryl-17,17-spirothiolan-substituerede steroider
ATE357914T1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien